The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Swine Vaccines Market In 2026 And 2030?
The swine vaccines market has demonstrated significant growth in recent years. It is projected to expand from $2.37 billion in 2025 to $2.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to several factors, including a high incidence of viral and bacterial infections in swine, an increasing demand for pork products, the expansion of commercial pig farming, the development of conventional live and inactivated vaccines, and a rising awareness of swine herd health management.
The swine vaccines market size is projected for significant expansion over the coming years, with an anticipated rise to $3.74 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.6%.
This expansion during the forecast period is fueled by several factors, including the adoption of DNA and recombinant vaccines, increased government backing for swine vaccination programs, the advancement of precision livestock farming, a concentrated effort on emerging infectious diseases, and the growing cold-chain infrastructure for vaccine distribution.
Major trends expected in the forecast period involve the creation of multi-valent swine vaccines, an increased focus on preventive swine healthcare, continued advancements in DNA and recombinant vaccines, the optimization of cold-chain vaccine distribution, and the development of rapid response vaccines for emerging swine diseases.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8163&type=smp
Which Significant Factors Are Encouraging Growth In The Swine Vaccines Market?
The rising prevalence of diseases in swine is expected to propel the swine vaccine market going forward. Swine disease is any divergence from an organism’s normal structural or functional condition accompanied by a few signs and symptoms of diseases such as pseudorabies, influenza. Diseases in swine are rising because intensive farming practices increase animal density, which accelerates disease transmission and makes outbreaks harder to control. Swine vaccines effectively combat the rising prevalence of diseases in swine by stimulating the immune system to recognize and respond to specific pathogens, thereby reducing infection rates, mitigating disease severity, and promoting overall herd health. For instance, in December 2023, according to the Swine Health Information Center, a US-based non-profit organization, in Poland, there has been a troubling increase in cases of African Swine Fever (ASF) among wild boars. As of early 2023, the country has recorded 2,347 confirmed ASF cases in wild boars, exceeding the total from 2022. Therefore, the rising prevalence of diseases in swine is expected to drive the growth of the market.
What Are The Major Segment Categories Within The Swine Vaccines Market?
The swine vaccines market covered in this report is segmented –
1) By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
2) By Disease: Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies
4) By Application: Government Tender, Market Sales
Subsegments:
1) By Attenuated Live Vaccines: Live Attenuated Virus Vaccines, Live Attenuated Bacterial Vaccines
2) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
4) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Nucleic Acid Vaccines
5) By Recombinant Vaccines: Recombinant Vector Vaccines, Recombinant Protein Vaccines
What Trends Are Affecting The Swine Vaccines Market Dynamics?
Major companies operating in the swine vaccine market are increasing their focus on introducing innovative vaccines, such as Circumvent CML, to gain a competitive edge. Circumvent CML is a vaccine designed to protect swine herds against diseases, enhancing overall swine health and productivity. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched a new 3-in-one swine vaccine called Circumvent CML, which controls for the diseases Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. This new vaccine is built on Merck’s foundation of tried-and-true, proven antigens and adjuvant systems that have been available in Circumvent PCV-M G2 and their standalone product, Porcilis Ileitis.
Who Are The Key Market Participants In The Swine Vaccines Market?
North America was the largest region in the swine vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Swine Vaccines Market Report:
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
What Is The Largest Regional Market In The Swine Vaccines Market?
North America was the largest region in the swine vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Swine Vaccines Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=8163&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model